Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenting Luo

Showing results (91-100 of 170) with videos related to

Pageof 17
Sort By:
Antibody Therapeutics|February 11, 2022
Novel development strategies and challenges for anti-Her2 antibody-drug conjugatesXinling Zhang, Andrew C Huang, Fahai Chen, et al.
Plos Genetics|July 23, 2013
The conserved intronic cleavage and polyadenylation site of CstF-77 gene imparts control of 3' end processing activity through feedback autoregulation and by U1 snRNPWenting Luo, Zhe Ji, Zhenhua Pan, et al.
Plos One|November 23, 2013
Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progressionMin Zhang, Wenting Luo, Bo Huang, et al.
International Journal of Molecular Sciences|May 27, 2026
Quercetin Suppresses Uterine Leiomyoma Progression by Modulating METTL3-Mediated MAPK SignalingWenting Luo, Xuan Yang, Yu Liu, et al.
Plos One|June 6, 2012
Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancerHaiying Li, Liangliang Sun, Zhongping Tang, et al.
Targeted Oncology|January 13, 2019
Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer TherapyZhuanglin Li, Mingxue Wang, Xuejing Yao, et al.
Frontiers in Bioscience (Landmark Edition)|January 5, 2024
Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic StrategiesJian Xia, Meiling Chen, Heng Shao, et al.
Cytokine|September 10, 2021
Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019Hao Chen, Rundong Qin, Zhifeng Huang, et al.
Plos One|June 24, 2011
CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cellsYing Xu, Lifeng Liu, Xueshan Qiu, et al.
BMC Cancer|February 17, 2010
TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cellsSiyang Zhang, Dawei Guo, Wenting Luo, et al.
Pageof 17

Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
Antibody Therapeutics|February 11, 2022
Novel development strategies and challenges for anti-Her2 antibody-drug conjugatesXinling Zhang, Andrew C Huang, Fahai Chen, et al.
Plos Genetics|July 23, 2013
The conserved intronic cleavage and polyadenylation site of CstF-77 gene imparts control of 3' end processing activity through feedback autoregulation and by U1 snRNPWenting Luo, Zhe Ji, Zhenhua Pan, et al.
Plos One|November 23, 2013
Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progressionMin Zhang, Wenting Luo, Bo Huang, et al.
International Journal of Molecular Sciences|May 27, 2026
Quercetin Suppresses Uterine Leiomyoma Progression by Modulating METTL3-Mediated MAPK SignalingWenting Luo, Xuan Yang, Yu Liu, et al.
Plos One|June 6, 2012
Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancerHaiying Li, Liangliang Sun, Zhongping Tang, et al.
Targeted Oncology|January 13, 2019
Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer TherapyZhuanglin Li, Mingxue Wang, Xuejing Yao, et al.
Frontiers in Bioscience (Landmark Edition)|January 5, 2024
Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic StrategiesJian Xia, Meiling Chen, Heng Shao, et al.
Cytokine|September 10, 2021
Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019Hao Chen, Rundong Qin, Zhifeng Huang, et al.
Plos One|June 24, 2011
CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cellsYing Xu, Lifeng Liu, Xueshan Qiu, et al.
BMC Cancer|February 17, 2010
TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cellsSiyang Zhang, Dawei Guo, Wenting Luo, et al.
Pageof 17